DJ Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Thursday When Compared To Competitors Despite Daily Gains
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. $(CRBP)$ inched 0.23% higher to $13.33 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.04% to 42,342.24 and the NASDAQ Composite Index falling 0.10% to 19,372.77.
Corbus Pharmaceuticals Holdings Inc. closed $48.57 short of its 52-week high ($61.90), which the company reached on July 31st.
The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Vanda Pharmaceuticals Inc. $(VNDA)$ rose 1.76% to $4.63, Fortress Biotech Inc. (FBIO) fell 1.69% to $1.74, and Viking Therapeutics Inc. $(VKTX)$ rose 8.39% to $41.49.
Trading volume (263,982) remained 63,964 below its 50-day average volume of 327,946.
Data source: Dow Jones Market Data, FactSet. Data compiled December 19, 2024.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
December 19, 2024 17:31 ET (22:31 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Comments